Cargando…
Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey
Background: Despite special global considerations which have been made to prioritize vaccination of people with multiple sclerosis (MS), some are reluctant to get vaccinated. This study was aimed to evaluate the attitude toward coronavirus disease-2019 (COVID-19) vaccine and its probable correlation...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189200/ https://www.ncbi.nlm.nih.gov/pubmed/38011337 http://dx.doi.org/10.18502/cjn.v21i4.11720 |
_version_ | 1785043034918879232 |
---|---|
author | Fattahi, Mohammad Reza Iranmehr, Arad Saeedi, Roghayyeh Sahraian, Mohammad Ali Doosti, Rozita Moghadasi, Abdorreza Naser |
author_facet | Fattahi, Mohammad Reza Iranmehr, Arad Saeedi, Roghayyeh Sahraian, Mohammad Ali Doosti, Rozita Moghadasi, Abdorreza Naser |
author_sort | Fattahi, Mohammad Reza |
collection | PubMed |
description | Background: Despite special global considerations which have been made to prioritize vaccination of people with multiple sclerosis (MS), some are reluctant to get vaccinated. This study was aimed to evaluate the attitude toward coronavirus disease-2019 (COVID-19) vaccine and its probable correlations. Methods: Considering the study objectives, two valid questionnaires including Fear of COVID-19 Scale (FCV-19S) and attitude questionnaires were administered pre and post COVID-19 vaccination among people with MS. Results: The questionnaires were administered among 349 people with MS pre and post vaccination. The mean age of participants was 38.78 ± 8.68 (range: 19 to 64) years. They all received the first dose of COVID-19 vaccine (Sinopharm). Although about 90% of participants felt satisfied after getting vaccinated and respected the preventive actions like social distancing and wearing face mask after vaccination, about 40% of them did not recommend vaccination to other patients. None of the demographic data was predictor of attitude score in COVID-19 vaccine and the only effective factor regarding fear of COVID-19 among people with MS was gender (P = 0.001). It was found that the more a patient’s fear score was, the more he/she felt satisfied after vaccination. Those patients who had got the influenza vaccine last year felt more satisfied with the vaccine and accepted the COVID-19 vaccine easier than others. Conclusion: This study revealed that there was an inverse correlation between fear of coronavirus and less trust in the vaccine in patients with MS. However, it should be mentioned that the patients felt more satisfied after COVID-19 vaccination. |
format | Online Article Text |
id | pubmed-10189200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-101892002023-05-18 Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey Fattahi, Mohammad Reza Iranmehr, Arad Saeedi, Roghayyeh Sahraian, Mohammad Ali Doosti, Rozita Moghadasi, Abdorreza Naser Curr J Neurol Original Article Background: Despite special global considerations which have been made to prioritize vaccination of people with multiple sclerosis (MS), some are reluctant to get vaccinated. This study was aimed to evaluate the attitude toward coronavirus disease-2019 (COVID-19) vaccine and its probable correlations. Methods: Considering the study objectives, two valid questionnaires including Fear of COVID-19 Scale (FCV-19S) and attitude questionnaires were administered pre and post COVID-19 vaccination among people with MS. Results: The questionnaires were administered among 349 people with MS pre and post vaccination. The mean age of participants was 38.78 ± 8.68 (range: 19 to 64) years. They all received the first dose of COVID-19 vaccine (Sinopharm). Although about 90% of participants felt satisfied after getting vaccinated and respected the preventive actions like social distancing and wearing face mask after vaccination, about 40% of them did not recommend vaccination to other patients. None of the demographic data was predictor of attitude score in COVID-19 vaccine and the only effective factor regarding fear of COVID-19 among people with MS was gender (P = 0.001). It was found that the more a patient’s fear score was, the more he/she felt satisfied after vaccination. Those patients who had got the influenza vaccine last year felt more satisfied with the vaccine and accepted the COVID-19 vaccine easier than others. Conclusion: This study revealed that there was an inverse correlation between fear of coronavirus and less trust in the vaccine in patients with MS. However, it should be mentioned that the patients felt more satisfied after COVID-19 vaccination. Tehran University of Medical Sciences 2022-10-07 /pmc/articles/PMC10189200/ /pubmed/38011337 http://dx.doi.org/10.18502/cjn.v21i4.11720 Text en Copyright © 2022 Iranian Neurological Association, and Tehran University of Medical Sciences Published by Tehran University of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
spellingShingle | Original Article Fattahi, Mohammad Reza Iranmehr, Arad Saeedi, Roghayyeh Sahraian, Mohammad Ali Doosti, Rozita Moghadasi, Abdorreza Naser Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey |
title | Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey |
title_full | Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey |
title_fullStr | Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey |
title_full_unstemmed | Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey |
title_short | Assessment of COVID-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: A cross-sectional survey |
title_sort | assessment of covid-19 vaccine attitude in people with multiple sclerosis, its correlation with demographic factors, and fear of coronavirus: a cross-sectional survey |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189200/ https://www.ncbi.nlm.nih.gov/pubmed/38011337 http://dx.doi.org/10.18502/cjn.v21i4.11720 |
work_keys_str_mv | AT fattahimohammadreza assessmentofcovid19vaccineattitudeinpeoplewithmultiplesclerosisitscorrelationwithdemographicfactorsandfearofcoronavirusacrosssectionalsurvey AT iranmehrarad assessmentofcovid19vaccineattitudeinpeoplewithmultiplesclerosisitscorrelationwithdemographicfactorsandfearofcoronavirusacrosssectionalsurvey AT saeediroghayyeh assessmentofcovid19vaccineattitudeinpeoplewithmultiplesclerosisitscorrelationwithdemographicfactorsandfearofcoronavirusacrosssectionalsurvey AT sahraianmohammadali assessmentofcovid19vaccineattitudeinpeoplewithmultiplesclerosisitscorrelationwithdemographicfactorsandfearofcoronavirusacrosssectionalsurvey AT doostirozita assessmentofcovid19vaccineattitudeinpeoplewithmultiplesclerosisitscorrelationwithdemographicfactorsandfearofcoronavirusacrosssectionalsurvey AT moghadasiabdorrezanaser assessmentofcovid19vaccineattitudeinpeoplewithmultiplesclerosisitscorrelationwithdemographicfactorsandfearofcoronavirusacrosssectionalsurvey |